LONDON, March 5, 2026, 08:21 GMT
- Hindustan Unilever says it has sold its entire 19.8% holding in Nutritionalab for about 3.07 billion rupees
- The sale follows a February plan to divest the stake as part of a “fewer, bigger bets” strategy
- Unilever is pushing premium beauty and wellbeing in India as competition intensifies
Unilever PLC’s Indian unit Hindustan Unilever said it has completed the sale of its entire shareholding in Nutritionalab Private Limited for about 3.07 billion Indian rupees, according to a stock exchange filing dated March 4. The filing said the company sold its full 19.8% holding and made the disclosure under India’s “Regulation 30” listing rules, which require listed firms to report material events. 1
The disposal is not a group-shifting deal on its own. It matters because Unilever is still trying to prove that a sharper focus on higher-margin categories can hold up in uneven demand, especially in big emerging markets.
India is also where the fight is getting messy: more sales are moving online, new brands can scale quickly, and the large consumer groups have been forced into faster portfolio calls. Exits can be as telling as acquisitions.
Hindustan Unilever said in February its board had approved selling the Nutritionalab stake to USV Private Limited, framing it as part of a portfolio reset built around “fewer, bigger bets”. Chief executive Priya Nair said health and wellbeing was “an important growth vector”, and tied the reshuffle to plans to scale brands using the company’s distribution and science capabilities. 2
Hindustan Unilever has also flagged capital spending to expand capacity in premium categories. Akshay D’Souza, an independent consumer goods consultant, said the company is feeling the pull of digital channels and direct-to-consumer, or D2C, brands — labels that sell mainly online, straight to shoppers. “If you look at personal care, for example, you’ve seen a large flurry of D2C brands,” he said. Unilever CEO Fernando Fernandez has said the group is doubling down on beauty and personal care, with an emphasis on premium and e-commerce in key markets including India. 3
Pressure on pricing has been one of the drivers. Hindustan Unilever has cut prices in some categories to fend off competition, Reuters has reported, including against Ariel detergent maker Procter & Gamble and India’s Godrej Consumer Products. Ajay Thakur, a research analyst at Anand Rathi Institutional Equities, called the company’s recent volume growth “a bright spot” even as margins tightened. 4
For the parent, the backdrop is bigger than India. Unilever has warned that 2026 underlying sales growth is likely to land at the bottom end of its forecast range after a slowdown in the United States and Europe, and it has also launched a 1.5 billion euro share buyback. “There are signs of progress at Unilever… however we think it will take time,” RBC Capital Markets analyst James Edwardes Jones wrote in a note after the update. 5
The Nutritionalab sale looks like tidy-up work, not a pivot. Still, it fits a pattern: sell what does not scale, back what might, and keep moving.
But the risk is that the market does not wait. If consumers trade down, if online challengers keep taking share, or if premium bets take longer to mature, Unilever’s “fewer, bigger” plan can start to feel like “fewer, slower.”
The filing did not break out any financial impact beyond the sale price. Investors will now look for how quickly the Indian unit and the parent turn those reshaped bets into steadier volumes and margins.
